Form 4: Bicycle Therapeutics COO Sells Shares to Cover Tax Obligations

Alistair Milnes, Chief Operating Officer of Bicycle Therapeutics plc, sold 955 ordinary shares on April 3, 2024, to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

• Alistair Milnes, the Chief Operating Officer of Bicycle Therapeutics plc, reported a transaction involving the sale of ordinary shares.
• On April 3, 2024, Milnes sold 955 ordinary shares at a weighted average price of $23.81.
• The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
• Following the transaction, Milnes beneficially owns 72,241 ordinary shares.
• The sale was mandated by the reporting person's award agreement that requires the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary sale by the reporting person.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes on RSU vesting) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction is a standard 'sell to cover' arrangement, common for executives receiving equity compensation.

Stakeholder Impact

• The sale of shares by the COO could have a minor, temporary impact on the stock price, but is unlikely to be significant given the reason for the sale.

Key Dates